about
Oxytocin receptor binding and uterotonic activity of carbetocin and its metabolites following enzymatic degradationFractional flow reserve versus angiography for guiding percutaneous coronary interventionDesensitization of beta2-adrenoceptor function in non-pregnant rat myometrium is modulated by sex steroidsCardiac symptoms before sudden cardiac death caused by coronary artery disease: a nationwide study among young Danish people.Predictors and prognostic value of left atrial remodelling after acute myocardial infarction.Optimal timing of coronary invasive strategy in non-ST-segment elevation acute coronary syndromes: a systematic review and meta-analysis.Cardioprotective effects of ischemic postconditioning in patients treated with primary percutaneous coronary intervention, evaluated by magnetic resonance.Comparison of paclitaxel- and sirolimus-eluting stents in everyday clinical practice: the SORT OUT II randomized trial.Exenatide reduces final infarct size in patients with ST-segment-elevation myocardial infarction and short-duration of ischemia.Data on administration of cyclosporine, nicorandil, metoprolol on reperfusion related outcomes in ST-segment Elevation Myocardial Infarction treated with percutaneous coronary intervention.Conditioning techniques and ischemic reperfusion injury in relation to on-pump cardiac surgery.A mismatch index based on the difference between measured left ventricular ejection fraction and that estimated by infarct size at three months following reperfused acute myocardial infarction.[Percutaneous aortic valve replacement - initial experience and results].Clinical benefit of drugs targeting mitochondrial function as an adjunct to reperfusion in ST-segment elevation myocardial infarction: A meta-analysis of randomized clinical trials.Fractional flow reserve versus angiography for guidance of PCI in patients with multivessel coronary artery disease (FAME): 5-year follow-up of a randomised controlled trial.Factors Associated With and Outcomes After Ventricular Fibrillation Before and During Primary Angioplasty in Patients With ST-Segment Elevation Myocardial Infarction.The Third DANish Study of Optimal Acute Treatment of Patients with ST-segment Elevation Myocardial Infarction: Ischemic postconditioning or deferred stent implantation versus conventional primary angioplasty and complete revascularization versus tre[Glucagon-like peptide-1: a cardiological perspective].Efficacy and safety of zotarolimus-eluting and sirolimus-eluting coronary stents in routine clinical care (SORT OUT III): a randomised controlled superiority trial.The regulation by ovarian steroids of prostaglandin synthesis and prostaglandin-induced contractility in non-pregnant rat myometrium. Modulating effects of isoproterenol.Optimal catchment area and primary PCI centre volume revisited: a single-centre experience in transition from high-volume centre to "mega centre" for patients with ST-segment elevation myocardial infarction.Drug-eluting versus bare metal stents in patients with st-segment-elevation myocardial infarction: eight-month follow-up in the Drug Elution and Distal Protection in Acute Myocardial Infarction (DEDICATION) trial.Measurements of pericardial adipose tissue using contrast enhanced cardiac multidetector computed tomography--comparison with cardiac magnetic resonance imaging.A novel prehospital electrocardiogram score predicts myocardial salvage in patients with ST-segment elevation myocardial infarction evaluated by cardiac magnetic resonance.[A new percutan assist device for treatment of fulminant myocarditis].Prognostic importance of complete atrioventricular block complicating acute myocardial infarction.Long-term outcome after drug-eluting versus bare-metal stent implantation in patients with ST-segment elevation myocardial infarction: 5 years follow-up from the randomized DEDICATION trial (Drug Elution and Distal Protection in Acute Myocardial InfFeasibility and safety of prehospital administration of bivalirudin in patients with ST-elevation myocardial infarction.Termination of dobutamine infusion causes transient rebound left heart diastolic dysfunction in healthy elderly women but not in men: a cardiac magnetic resonance study.Hypercoagulation assessed by thromboelastography is neither related to infarct size nor to clinical outcome after primary percutaneous coronary intervention.Long-term outcome in patients treated with sirolimus-eluting stents in complex coronary artery lesions: 3-year results of the SCANDSTENT (Stenting Coronary Arteries in Non-Stress/Benestent Disease) trial.Deferred stent implantation in patients with ST-segment elevation myocardial infarction: a pilot study.Is ischemic postconditioning in STEMI worth pursuing?Impact of acute hyperglycemia on myocardial infarct size, area at risk, and salvage in patients with STEMI and the association with exenatide treatment: results from a randomized study.Correlating infarct size and patient prognosis: are cardiac biomarkers truly insufficient? Reply.Restenosis in coronary bare metal stents. Importance of time to follow-up: a comparison of coronary angiograms 6 months and 4 years after implantation.Final infarct size measured by cardiovascular magnetic resonance in patients with ST elevation myocardial infarction predicts long-term clinical outcome: an observational study.Impact of system delay on infarct size, myocardial salvage index, and left ventricular function in patients with ST-segment elevation myocardial infarction.ST peak during primary percutaneous coronary intervention predicts final infarct size, left ventricular function, and clinical outcome.Comparison of Selvester QRS score with magnetic resonance imaging measured infarct size in patients with ST elevation myocardial infarction.
P50
Q28284390-76454970-39A8-48C9-ABAC-5072CEB293C2Q28306779-E1C00293-3710-44A4-A78B-5CDEEA345020Q28570144-248DE097-7C1D-4EFE-839F-6DA1B8F74C4FQ34338385-5E52A3B5-1935-483D-A597-289F95F83A27Q35722052-DAE08070-A5A3-4699-9C43-F9CD069AEABEQ38082692-5F79096E-5587-4CE5-978F-88390D974240Q38376053-1249CB93-ABCD-4FD0-811B-C80C78FD1963Q38392662-32E84BC6-F71C-49CC-B54E-19E6E986CB32Q38473330-D86D360D-FE42-46BC-A956-C2B7EB6FD117Q38631258-605C44D4-5A54-480E-B10C-C95DEA8B84DBQ39188086-A3F4C9B2-E621-4F50-99DD-226B80B266B0Q39283681-159E050A-3B9D-4696-A761-84FAABF5EE1EQ39304207-75C031FE-C162-4FA3-B331-286A69B9D321Q39386823-63E44AE4-4977-4067-969F-B8853CD45AE8Q40581096-B4257236-24CA-4474-9CC8-9EA82E7A3596Q40762804-F3B61A77-1581-4697-AF50-B685E008FB0CQ41743994-D193FBFB-1B88-4B3F-AF8A-28536ECC5DBDQ42852755-C1205FDC-0C4C-4E6B-ADC6-83AFC8D07B0AQ43128990-5E592840-204F-4016-9EAA-0E6EB8C3FDADQ43543381-9B0B0A33-CFE7-41C0-BE8C-F65CC4A45665Q43585011-06E0553C-7402-444D-8427-E93CBEED6D6CQ44003520-97D242E4-70A3-4C9A-B86C-A1139F97C427Q44125019-CDD33EFE-E6CC-450F-9FCC-6988534799BCQ44715111-513084E5-FA8B-43EC-9149-F1D60DD3AD6BQ44809733-0EF84D86-BFC5-42FF-B260-CC922150C1E1Q45128983-BB2FFD52-288F-4FAD-97B8-60AD2F3BBC18Q45911756-F6C60FC9-7B37-474F-BF35-251845E9ECACQ45962796-E958AC78-5C94-45CC-81B4-30415B784898Q46014909-5EDB2C4B-7987-4C84-BA38-670846FEA586Q46472467-9542AC87-4BFD-4C1A-94E8-7E7C2A80676AQ46579604-565631C1-ED73-4D1F-8ACB-A6B361B44626Q46858489-AB931FC3-2196-4820-B71D-9DFBA855FF4AQ47160131-F29168CB-0EF7-47E0-8E9F-7043324163A9Q47180985-5D862D83-CBA0-4FD4-B6C6-A8295C1142E5Q47208094-BA385D37-591F-412C-A371-49B4C72A009FQ47217489-327A279B-1F15-4B95-98E1-03D7B657CDA5Q47270854-8ADB1ED7-06A5-4974-AFB9-CF6280CD6DC9Q47279046-1AF1D786-15B0-4299-8F0B-3A896AB3F385Q47295477-719B6383-DB15-4210-8DC8-543D4EFA1B66Q47312235-FDE2DE8C-3631-4E27-B025-02A87FBA89FD
P50
description
onderzoeker
@nl
researcher, Rigshospitalet
@en
հետազոտող
@hy
name
Thomas Engstrøm
@ast
Thomas Engstrøm
@da
Thomas Engstrøm
@de
Thomas Engstrøm
@en
Thomas Engstrøm
@es
Thomas Engstrøm
@fo
Thomas Engstrøm
@fr
Thomas Engstrøm
@is
Thomas Engstrøm
@kl
Thomas Engstrøm
@nb
type
label
Thomas Engstrøm
@ast
Thomas Engstrøm
@da
Thomas Engstrøm
@de
Thomas Engstrøm
@en
Thomas Engstrøm
@es
Thomas Engstrøm
@fo
Thomas Engstrøm
@fr
Thomas Engstrøm
@is
Thomas Engstrøm
@kl
Thomas Engstrøm
@nb
prefLabel
Thomas Engstrøm
@ast
Thomas Engstrøm
@da
Thomas Engstrøm
@de
Thomas Engstrøm
@en
Thomas Engstrøm
@es
Thomas Engstrøm
@fo
Thomas Engstrøm
@fr
Thomas Engstrøm
@is
Thomas Engstrøm
@kl
Thomas Engstrøm
@nb
P106
P108
P21
P31
P496
0000-0001-5436-9194